References

  1. Ward MM, Pyun E, Studenski S. Causes of death in systemic lupus erythematosus. Arthritis Rheum. 1995;38(10):1492-9. PubMed | Google Scholar

  2. Tazi Mezalek Z, Hammouche H, Ammouri W, Maamar M, Adnaoui M, Cacoub P. Athérosclérose au cours du lupus érythémateux systémique. Presse Med. 2014; 43(10):1034-47. PubMed | Google Scholar

  3. Urowitz MB, Bookman AAM, Koehler BE, Gordon DA, Smuthe HA, Ogryzlo MA. The bimodal mortality pattern of systemic lupus erythematosus. Am J Med. 1976; 60(2): 221-5. PubMed | Google Scholar

  4. Hak AE, Karlson EW, Feskanich D, Stampfer MJ, Costenbader KH. Systemic lupus erythematosus and the risk of cardiovascular disease: results from the nurses? Health study. Arthritis Rheum. 2009; 61(10):1396-402. PubMed | Google Scholar

  5. Arnaud L et al. Dépistage et prise en charge du risque cardiovasculaire au cours du lupus systémique: élaboration de recommandations pour la pratique clinique, à partir d'une analyse d'experts. Rev Med Interne (2014), http://dx.doi.org/10.1016/j.revmed.2014.10.009. Google Scholar

  6. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997; 40(9):1725. PubMed | Google Scholar

  7. Utilisation et interprétation de l'anthropométrie. Rapport d'un Comité d'experts. Genève, Organisation mondiale de la Santé, 1995 (OMS, Série de Rapports techniques. No 854:367. Google Scholar

  8. Markowitz GS, D'Agati VD. The ISN/RPS 2003 classification of lupus nephritis: an assessment at 3 years. Kidney Int. 2007; 71(6):491-495. PubMed | Google Scholar

  9. Esdaile JM, Abrahamowicz M, Grodzicky T, Li Y, Panaritis C, Du Berger R et al. Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus. Arthritis Rheum. 2001;44(10):2331-7. PubMed | Google Scholar

  10. Haque S, Gordon C, Isenberg D, Rahman A, Lanyon P, Bell A et al. Risk factors for clinical coronary heart disease in systemic lupus erythematosus: the lupus and athero- sclerosis evaluation of risk (LASER) study. J Rheumatol. 2010; 37(10):322-9. PubMed | Google Scholar

  11. Arnaud L, Mathian A, Bruckert E, Amoura Z. Le risque cardiovasculaire au cours du lupus systémique. Rev Med Int. 2014; 35(11):723-729. PubMed | Google Scholar

  12. Urowitz MB, Gladman D, Ibañez D, Bae SC, Sanchez-Guerrero J, Gordon C et al. Athero- sclerotic vascular events in a multinational inception cohort of systemic lupus erythe- matosus. Arthritis Care Res. 2010;62(6):881-7. PubMed | Google Scholar

  13. El Magdami M, Ahmed Y, Turkic W, Yates AP, Sheikh N, Bernstein RM et al. Hyper- insulinemia, insulin resistance and circulating oxidised low-density lipoprotein in women with systemic lupus erythematosus. J Rheumatol. 2006; 33(1):50-6. PubMed | Google Scholar

  14. Parker B, Urowitz MB, Gladman DD, Lunt M, Bae SC, Sanchez-Guerrero J et al. Clinical associations of the metabolic syndrome in systemic lupus erythematosus: data from an international inception cohort. Ann Rheum Dis. 2013; 72(8):1308-14. PubMed | Google Scholar

  15. Selzer F, Sutton-Tyrrell K, Fidgerald SG, Pratt JE, Tracy RP, Kuller LH et al. Comparison of risk factors for vascular disease in the carotid artery an aorta in woman with systemic lupus erythematosus. Arthritis Rheum. 2004; 50(1): 151-9. PubMed | Google Scholar

  16. Asanuma Y, Chung CP, Oeser A, Shintani A, Stanley E, Raggi P et al. Increased concentration of pro-atherogenic inflammatory cytokines in systemic lupus erythematosus: relationship to cardiovascular risk factors. J Rheumatol. 2006;33(3):539-45. PubMed | Google Scholar

  17. Roman MJ, Crow MK, Lockshin MD, Deve-reux RB, Paget SA, Sammaritano L et al. Rate and determinants of progression of atherosclerosis in systemic lupus erythe- matosus. Arthritis Rheum. 2007; 56(10):3412-9. PubMed | Google Scholar

  18. Leong KH, Koh ET, Feng PH, Boey ML. Lipid profiles in patients with systemic lupus erythematosus. J Rheumatol. 1994; 21(7): 1264-7. PubMed | Google Scholar

  19. Roman MJ, Shanker BA, Davis A, Lockshin MD, Sammaritano L, Simantov R et al. Prevalence and correlates of atherosclerosis in systemic lupus erythematosus. N Engl J Med. 2003;349(25):2399-406. PubMed | Google Scholar

  20. Jung H, Bobba R, Su J, Shariati-Sarabi Z, Gladman DD et al. The protective effect of antimalarial drugs on thrombovascular events in systemic lupus erythematosus. Arthritis Rheum. 2010;62(3):863-8. PubMed | Google Scholar